Skip to content

Dokter Carolien Ceulemans

Active Private limited companyfounded 2019active for 6 yearsSpreet 42, 2500 LierKBO/BCE: BE 0739.864.233

Lifetime

6 annual accounts with figures on one time axis
peak of €242,977 in 2024
€186,117▼ 23.4%
peak of €178,991 in 2024
€134,748▼ 24.7%
peak of €317,953 in 2022
€2,000unchanged
€146,676▼ 31.2%
Board1 name since 2019
1 director
Documentsfilings and deeds
01-04-2026121 days before the deadline
2025micro format
Gross margin from €242,977 to €186,117Dividend €134,748Debts from €213,147 to €146,676Cash from €90,732 to €8,344

Key points

from the 2025 annual accounts

Equity

€2,000 from €317,953 in 2022

Equity fell by 99% in 3 years.

Turnover

≈ €350,000 estimated

The micro format states no turnover.

Debts

€146,676 99% of the balance sheet

Filings

6 annual accounts 4 late
AprilJune31 JulyOctober202020222024

The 2020 accounts came in latest, 90 days after the end of the period.

Position in the sector

€2,000

Less equity than 94% of companies in human health. Sector median €125,088 · 21,349 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Dokter Carolien Ceulemans has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Dokter Carolien Ceulemans. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 20-12-2019
  • 100 sharesdeed of 24-12-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0739864233
Incorporation Founding capital of €2,000, 100 shares · Founded by · appointed as director · published on 24-12-2019 · Gazette deed
First establishment Spreet 42, Lier
All 12 events

Comparable companies

same main activity, similar in size and age
Company
Dokter Carolien Ceulemans Lier €148,676 €186,117 1.3% -
Dokter Anne Van Baelen Kortrijk €155,116 €188,588 3.2% -
Dokter Galina Khorosheva Endocrinologie Leuven €155,150 €175,615 89.1% -
ITINERANCES 2020 Uccle €146,556 €171,207 0.7% -
Dr. Fabian Dhondt, urgentiearts Herent €157,708 €190,380 1.9% -
DOCTEUR LOUISA SOUKANE Sprimont €159,791 €197,206 1.6% -
DR. SHARI ANSEEUW Bruges €156,910 €184,841 86.0% -

These companies have the same main activity as Dokter Carolien Ceulemans: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €147,000 and €160,000, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 20-12-2019Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.298.002.3532500 Lier, since 20-12-2019
Financial year end
31 December
Peppol
Reachable since 03-02-2025
Company details

Annual accounts 2025

€148,676▼ 30.9%
Filing
Filed on 01-04-2026, 121 days before the end of the filing period
Financials

Insights on Dokter Carolien Ceulemans

Dokter Carolien Ceulemans files the micro format. That format states no turnover. The gross margin rose from €81,207 in 2020 to €186,117 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dokter Carolien Ceulemans

What is the company number of Dokter Carolien Ceulemans?
The company number of Dokter Carolien Ceulemans is 0739.864.233. The VAT number is the same number with BE in front: BE 0739.864.233.
Where is Dokter Carolien Ceulemans based?
The registered office is at Spreet 42, 2500 Lier.Company details
What does Dokter Carolien Ceulemans do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dokter Carolien Ceulemans?
Dokter Carolien Ceulemans is a private limited company (BV).
When was Dokter Carolien Ceulemans founded?
Dokter Carolien Ceulemans was founded on 20-12-2019.
Is Dokter Carolien Ceulemans still active?
Yes, Dokter Carolien Ceulemans is an active enterprise in the KBO register.
What is the turnover of Dokter Carolien Ceulemans?
The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €186,117 and 40 comparable companies (NACE 86220). It probably lies between €290,000 and €460,000.Financials
Is Dokter Carolien Ceulemans profitable?
In financial year 2025, Dokter Carolien Ceulemans made a profit of €134,748.
Where can I find the annual accounts of Dokter Carolien Ceulemans?
Dokter Carolien Ceulemans filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dokter Carolien Ceulemans due?
Dokter Carolien Ceulemans must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.